FDA has approved a single-injection hyaluronic acid (Durolane – Bioventus) and an ER formulation of the synthetic corticosteroid triamcinolone acetonide (Zilretta – Flexion) for intra-articular (IA) treatment of osteoarthritic knee pain. https://t.co/7rgsflNMVq